These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34209646)

  • 21. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
    Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
    Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.
    Wittmann P; Grubinger M; Gröger C; Huber H; Sieghart W; Peck-Radosavljevic M; Mikulits W
    BMC Cancer; 2015 Nov; 15():909. PubMed ID: 26573807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial-Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism.
    Soukupova J; Malfettone A; Bertran E; Hernández-Alvarez MI; Peñuelas-Haro I; Dituri F; Giannelli G; Zorzano A; Fabregat I
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives.
    Dituri F; Mancarella S; Cigliano A; Chieti A; Giannelli G
    Semin Liver Dis; 2019 Feb; 39(1):53-69. PubMed ID: 30586675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats.
    Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells.
    Moreno-Càceres J; Caballero-Díaz D; Nwosu ZC; Meyer C; López-Luque J; Malfettone A; Lastra R; Serrano T; Ramos E; Dooley S; Fabregat I
    Cell Death Dis; 2017 Oct; 8(10):e3098. PubMed ID: 29022911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting TGF-β signaling in hepatocellular carcinoma.
    Giannelli G; Mazzocca A; Fransvea E; Lahn M; Antonaci S
    Biochim Biophys Acta; 2011 Apr; 1815(2):214-23. PubMed ID: 21129443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X; Wu J; Jiang Q; Cheng H; Han JJ; Chen YG
    J Mol Cell Biol; 2018 Feb; 10(1):48-59. PubMed ID: 29036306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rationale for targeting TGF-β in chronic liver diseases.
    Giannelli G; Mikulits W; Dooley S; Fabregat I; Moustakas A; ten Dijke P; Portincasa P; Winter P; Janssen R; Leporatti S; Herrera B; Sanchez A
    Eur J Clin Invest; 2016 Apr; 46(4):349-61. PubMed ID: 26823073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.
    Peng R; Zhang PF; Yang X; Wei CY; Huang XY; Cai JB; Lu JC; Gao C; Sun HX; Gao Q; Bai DS; Shi GM; Ke AW; Fan J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):113. PubMed ID: 30836988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma.
    Gupta DK; Singh N; Sahu DK
    Cancer Growth Metastasis; 2014; 7():1-8. PubMed ID: 24741325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
    Li X; Zeng X
    Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.
    Shirai Y; Kawata S; Tamura S; Ito N; Tsushima H; Takaishi K; Kiso S; Matsuzawa Y
    Cancer; 1994 May; 73(9):2275-9. PubMed ID: 7513247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
    Su Q; Fan M; Wang J; Ullah A; Ghauri MA; Dai B; Zhan Y; Zhang D; Zhang Y
    Cell Death Dis; 2019 Dec; 10(12):939. PubMed ID: 31819036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
    Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
    Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z; Zhang Y; Xu Z
    J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
    Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
    Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β-catenin and TGF-β/EMT signaling pathways.
    Liu Z; Zhang Y; Xu Z
    J BUON; 2018; 23(1):185-187. PubMed ID: 29552781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
    Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.